Crossref
Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition
Klinická farmakologie a farmacie · 30.10.2025 · 39 (3) · 181-184
DOI: 10.36290/far.2025.063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinická farmakologie a farmacie, erschienen am 30.10.2025. Verfasst von Kateřina Skopalová. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Skopalová, K. (2025). Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition. Klinická farmakologie a farmacie, 39(3), 181-184. https://doi.org/10.36290/far.2025.063
Vancouver
Skopalová K. Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition. Klinická farmakologie a farmacie. 2025;39(3):181-184. doi:10.36290/far.2025.063
BibTeX
@article{Skopalov2025,
author = {Skopalová, Kateřina},
title = {Pharmacokinetic interactions of clozapine and olanzapine: case studies of drug modifications due to CYP1A2 inhibition},
journal = {Klinická farmakologie a farmacie},
year = {2025},
volume = {39},
number = {3},
pages = {181--184},
doi = {10.36290/far.2025.063}
}
EUVIMED